Google+ Badge

Wednesday, July 22, 2015

Cancer Research: Drug-encapsulating nanoparticle with bright bio-labels ♦ New options for cancer therapy ♦ State regulations linked to late cancer diagnoses

Drug-encapsulating nanoparticle with bright bio-labels measures how anticancer chemotherapy formulations enter cells Polymer nanoparticles that release medicine at controlled rates inside cells have the potential to enhance the efficacy of many clinical drugs. Researchers have now developed an eye-catching way to evaluate the performance of different polymer drug-delivery formulations using luminescent quantum dots as imaging labels.
Resveratrol, quercetin could provide new options for cancer therapy Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment, primarily by improving the efficacy and potential use of an existing chemotherapeutic cancer drug.
One-third of colorectal cancers diagnosed before 35 are hereditary Hereditary colorectal cancers, caused by inherited gene mutations, are relatively rare for most patients. However, researchers have discovered a particularly high prevalence of hereditary cancers among those diagnosed with the disease before the age of 35.
New method to deliver glucose to cancer cells could prove key to defeating deadly cancers Scientists have, for the first time, demonstrated the importance of sodium-dependent glucose transporters (SGLTs) in delivering glucose to pancreatic and prostate cancer cells. Their study results show promising evidence that current SGLT inhibitor drugs could potentially be used to block glucose uptake and reduce tumor growth in these cancers.

State regulations linked to late cancer diagnoses States' regulations of health insurance and practitioners significantly influence when patients receive colorectal or breast cancer diagnoses, especially among people younger than the Medicare-eligible age of 65.

No comments:

Post a Comment